Pediatric Hematology Oncology Journal最新文献

筛选
英文 中文
COVID-19 associated life-threatening immune-mediated thrombotic thrombocytopenic purpura in an adolescent girl 一名少女患上与 COVID-19 相关的、危及生命的免疫介导型血栓性血小板减少性紫癜
Pediatric Hematology Oncology Journal Pub Date : 2024-01-08 DOI: 10.1016/j.phoj.2024.01.003
Stalin Ramprakash , C.P. Raghuram , Anoop P , Veerabhadra Gupta , Sujatha Thyagarajan
{"title":"COVID-19 associated life-threatening immune-mediated thrombotic thrombocytopenic purpura in an adolescent girl","authors":"Stalin Ramprakash ,&nbsp;C.P. Raghuram ,&nbsp;Anoop P ,&nbsp;Veerabhadra Gupta ,&nbsp;Sujatha Thyagarajan","doi":"10.1016/j.phoj.2024.01.003","DOIUrl":"https://doi.org/10.1016/j.phoj.2024.01.003","url":null,"abstract":"<div><p>Acute COVID-19 infection typically results in mild disease in children, but can lead to several immune manifestations. One such severe manifestation is immune-mediated thrombotic thrombocytopenia (iTTP). It is exceedingly rare in children, and only a few cases have been reported worldwide. We report a case of severe iTTP in a 17-year-old girl. She was positive for COVID-19 infection by reverse-transcription polymerase chain reaction at presentation and had received a Covaxin injection two weeks earlier. She responded to therapeutic plasma exchange, corticosteroids, and rituximab. Early recognition of this complication and prompt initiation of therapeutic plasma exchange and corticosteroids is paramount to achieving a good outcome in this rare, life-threatening complication.</p></div>","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 1","pages":"Pages 24-27"},"PeriodicalIF":0.0,"publicationDate":"2024-01-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468124524000032/pdfft?md5=4fea6eb28a6f74808e6767561c1fc1f0&pid=1-s2.0-S2468124524000032-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139434027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spectrum of afibrinogenemia: Bleeding to thrombosis- retrospective analysis of five patients 纤维蛋白血症的范围:从出血到血栓形成--对五名患者的回顾性分析
Pediatric Hematology Oncology Journal Pub Date : 2024-01-05 DOI: 10.1016/j.phoj.2023.12.007
Sneha Waghela, Sujata Sharma, Nikita Shah, Harshada Uchil, Radha Ghildiyal
{"title":"Spectrum of afibrinogenemia: Bleeding to thrombosis- retrospective analysis of five patients","authors":"Sneha Waghela,&nbsp;Sujata Sharma,&nbsp;Nikita Shah,&nbsp;Harshada Uchil,&nbsp;Radha Ghildiyal","doi":"10.1016/j.phoj.2023.12.007","DOIUrl":"10.1016/j.phoj.2023.12.007","url":null,"abstract":"<div><h3>Background</h3><p>Afibrinogenemia is a rare disorder, with autosomal recessive inheritance, most often associated with consanguinity. To date, very few cases have been reported from India. The aim was to study the clinical heterogenicity of patients with afibrinogenemia.</p></div><div><h3>Case series</h3><p>We present a retrospective study of five patients with afibrinogenemia diagnosed at our institute. All five patients had bleeding as a primary symptom. The median age for the first episode of bleeding was 150 days (range: 2 days - 18 months). Four were born of third degree consanguineous couple. The male to female ratio was 0.66. One patient had thrombosis along with bleeding. All patients had normal platelet count with deranged prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time, and low to nil fibrinogen levels. All had at least one episode of deep bleeding. The sites of bleeding included: a) intracranial (n = 3), b) intramuscular (n = 1), and, c) hemarthrosis (n = 1).</p></div><div><h3>Conclusion</h3><p>Afibrinogenemia should be considered as a differential diagnosis in patients with bleeding from any site with prolongation of PT and APTT. Paradoxical arterial and venous thrombosis may be a manifestation, but is rare. Thrombotic phenotype requires management with fibrinogen infusion along with anti-coagulants.</p></div>","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 1","pages":"Pages 15-17"},"PeriodicalIF":0.0,"publicationDate":"2024-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468124523003546/pdfft?md5=346a5d411575c00f70c2bacd906b8f60&pid=1-s2.0-S2468124523003546-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139394062","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Withholding and withdrawal of life-sustaining therapy in terminally ill children with cancer: A position statement by the PHO chapter of the Indian Academy of Pediatrics 在癌症晚期患儿中暂停和撤消维持生命疗法:印度儿科学会 PHO 分会的立场声明
Pediatric Hematology Oncology Journal Pub Date : 2024-01-04 DOI: 10.1016/j.phoj.2024.01.002
Vikramjit S. Kanwar , Poonam Bagai , Anupama Borker , Veronique Dinand , Roop Gursahani , Krutika Kurhade , Manas Kalra , Smriti Khanna , Manjusha Nair , Amita Mahajan , Gayatri Palat , Raghwesh Ranjan , Santanu Sen , Lakshmi Shobhavat
{"title":"Withholding and withdrawal of life-sustaining therapy in terminally ill children with cancer: A position statement by the PHO chapter of the Indian Academy of Pediatrics","authors":"Vikramjit S. Kanwar ,&nbsp;Poonam Bagai ,&nbsp;Anupama Borker ,&nbsp;Veronique Dinand ,&nbsp;Roop Gursahani ,&nbsp;Krutika Kurhade ,&nbsp;Manas Kalra ,&nbsp;Smriti Khanna ,&nbsp;Manjusha Nair ,&nbsp;Amita Mahajan ,&nbsp;Gayatri Palat ,&nbsp;Raghwesh Ranjan ,&nbsp;Santanu Sen ,&nbsp;Lakshmi Shobhavat","doi":"10.1016/j.phoj.2024.01.002","DOIUrl":"10.1016/j.phoj.2024.01.002","url":null,"abstract":"<div><p>In the last four decades, survival in childhood cancer in India has improved significantly, however we increasingly face the question that has challenged providers in high-income countries: when care becomes futile and merely prolongs suffering, how should that be addressed? This position statement was prepared by a panel in the Pediatric Hematology-Oncology chapter of the Indian Academy of Pediatrics (IAP-PHO), with external experts, using a process endorsed by the Executive Committee of IAP-PHO. The panel consisted of providers and stakeholders who were committed to improving end-of-life care (EOLC) in children with cancer. Three case scenarios of terminally ill children with cancer were presented, and the various challenges of EOLC in each situation were brought up, including families who wanted everything possible done for their child and the fear of medicolegal issues by physicians. We emphasize the importance of involving palliative care services early in the process to ensure that families receive a consistent message about their child's outcome. With the recent Supreme Court of India decision, there is now a viable EOLC pathway to withdraw life-sustaining therapy (LST) from children who are terminally ill. We outline it and discuss the various barriers to the withdrawal of LST. Increased access to palliative medicine services, which currently exist sporadically across India, is a core necessity. IAP-PHO hopes to actively work with organizations representing colleagues in palliative care and intensive care, to see how we can improve EOLC in childhood cancer.</p></div>","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 1","pages":"Pages 18-23"},"PeriodicalIF":0.0,"publicationDate":"2024-01-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468124524000020/pdfft?md5=29e27c6a765aa9e53e4d25facf26f4fb&pid=1-s2.0-S2468124524000020-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139395720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Secondary hemophagocytic lymphohistiocytosis in a child with Sickle Cell Anemia and Hepatitis A and Hepatitis E co-infection: A case report 镰状细胞性贫血合并甲型肝炎和戊型肝炎患儿的继发性嗜血细胞淋巴组织细胞增多症:病例报告
Pediatric Hematology Oncology Journal Pub Date : 2024-01-02 DOI: 10.1016/j.phoj.2024.01.001
Govind Choudhary, Nida Mirza, Swati Patel
{"title":"Secondary hemophagocytic lymphohistiocytosis in a child with Sickle Cell Anemia and Hepatitis A and Hepatitis E co-infection: A case report","authors":"Govind Choudhary,&nbsp;Nida Mirza,&nbsp;Swati Patel","doi":"10.1016/j.phoj.2024.01.001","DOIUrl":"10.1016/j.phoj.2024.01.001","url":null,"abstract":"<div><h3>Background</h3><p>Secondary hemophagocytic lymphohistiocytosis (HLH) is a potentially fatal condition commonly triggered by infections. HLH secondary to hepatitis E or hepatitis A and E coinfection has been scarcely reported. Diagnosing HLH in sickle cell anemia can be tricky.</p></div><div><h3>Case report</h3><p>We present a 10-year-old boy, a known case of sickle cell anemia, who presented with acute viral hepatitis (HAV and HEV IgM positive). He initially improved with supportive management. However, on the fifth day of illness, he developed fever, tachypnea, and pancytopenia. Inflammatory markers, including serum ferritin, triglycerides, and D-dimer were raised. Bone marrow examination revealed hemophagocytosis. A diagnosis of sickle cell disease with HAV and HEV coinfection with secondary HLH was made. The patient responded to steroids and was well on follow-up after 3 months.</p></div><div><h3>Conclusion</h3><p>HAV and HEV coinfection with a background of sickle cell anemia with secondary HLH is very rare. Diagnosis of HLH in sickle cell anemia is challenging. Timely diagnosis and management of secondary HLH are vital for a favorable outcome.</p></div>","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 1","pages":"Pages 28-31"},"PeriodicalIF":0.0,"publicationDate":"2024-01-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2468124524000019/pdfft?md5=2c3d67761a2946829f395b8cd7baac31&pid=1-s2.0-S2468124524000019-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139455168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pre-transplant host status determines the outcomes in non-malignant disorders 移植前宿主状态决定非恶性疾病的预后
Pediatric Hematology Oncology Journal Pub Date : 2024-01-01 DOI: 10.1016/j.phoj.2024.11.091
Darshan Kataria, Sanaa Khan, Ambreen Pandrowala, Prashant Hiwarkar
{"title":"Pre-transplant host status determines the outcomes in non-malignant disorders","authors":"Darshan Kataria,&nbsp;Sanaa Khan,&nbsp;Ambreen Pandrowala,&nbsp;Prashant Hiwarkar","doi":"10.1016/j.phoj.2024.11.091","DOIUrl":"10.1016/j.phoj.2024.11.091","url":null,"abstract":"","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 4","pages":"Page S5"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142703762","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Treosulfan associated knock knees in children post hematopoietic stem cell transplantation - Report from a 15 year follow study 造血干细胞移植后儿童与硫丹相关的膝关节损伤--15 年跟踪研究报告
Pediatric Hematology Oncology Journal Pub Date : 2024-01-01 DOI: 10.1016/j.phoj.2024.10.060
Anupama Nair, Vijayshree Muthukumar, Nithya Seshadri, Minakshi Lalchand Balwani, Anuraag Reddy Nalla, Ramya Uppuluri, Revathi Raj
{"title":"Treosulfan associated knock knees in children post hematopoietic stem cell transplantation - Report from a 15 year follow study","authors":"Anupama Nair,&nbsp;Vijayshree Muthukumar,&nbsp;Nithya Seshadri,&nbsp;Minakshi Lalchand Balwani,&nbsp;Anuraag Reddy Nalla,&nbsp;Ramya Uppuluri,&nbsp;Revathi Raj","doi":"10.1016/j.phoj.2024.10.060","DOIUrl":"10.1016/j.phoj.2024.10.060","url":null,"abstract":"","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 4","pages":"Page S29"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142702200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinico haematological profile in malnourished children 营养不良儿童的临床血液学特征
Pediatric Hematology Oncology Journal Pub Date : 2024-01-01 DOI: 10.1016/j.phoj.2024.10.006
Kritika Arora, Ravinder k gupta
{"title":"Clinico haematological profile in malnourished children","authors":"Kritika Arora,&nbsp;Ravinder k gupta","doi":"10.1016/j.phoj.2024.10.006","DOIUrl":"10.1016/j.phoj.2024.10.006","url":null,"abstract":"","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 4","pages":"Page S45"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142697381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Copy number alterations in Pb acute lymphoblastic leukaemia (Pb-all) and proposal for a new integrated risk stratification system Pb 急性淋巴细胞白血病(Pb-all)的拷贝数改变和新的综合风险分层系统建议
Pediatric Hematology Oncology Journal Pub Date : 2024-01-01 DOI: 10.1016/j.phoj.2024.11.114
Ajmeera Azeez, Amita Trehan, Prateek Bhatia, Minu Singh
{"title":"Copy number alterations in Pb acute lymphoblastic leukaemia (Pb-all) and proposal for a new integrated risk stratification system","authors":"Ajmeera Azeez,&nbsp;Amita Trehan,&nbsp;Prateek Bhatia,&nbsp;Minu Singh","doi":"10.1016/j.phoj.2024.11.114","DOIUrl":"10.1016/j.phoj.2024.11.114","url":null,"abstract":"","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 4","pages":"Pages S3-S4"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142697605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of alternate day versus twice daily oral iron therapy in children with iron deficiency anemia – A randomized control trial 缺铁性贫血儿童隔日口服铁剂治疗与每日两次口服铁剂治疗的疗效--随机对照试验
Pediatric Hematology Oncology Journal Pub Date : 2024-01-01 DOI: 10.1016/j.phoj.2024.11.095
Pranati Grover, Abhilasha Sampagar
{"title":"Efficacy of alternate day versus twice daily oral iron therapy in children with iron deficiency anemia – A randomized control trial","authors":"Pranati Grover,&nbsp;Abhilasha Sampagar","doi":"10.1016/j.phoj.2024.11.095","DOIUrl":"10.1016/j.phoj.2024.11.095","url":null,"abstract":"","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 4","pages":"Page S7"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142697607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world outcomes of children treated for high-risk neuroblastoma and the challenge in identifying the ultra-high-risk 高风险神经母细胞瘤患儿的实际治疗效果以及识别超高风险所面临的挑战
Pediatric Hematology Oncology Journal Pub Date : 2024-01-01 DOI: 10.1016/j.phoj.2024.11.117
Aditi Dwivedi, Venkata Rama Mohan Gollamudi, Sneha Shah, Maya Prasad, Badira Cheriyalinkal Parambil, Sajid Qureshi, Siddhartha Laskar, Nehal Khanna, Vasundara Patel, Akshay Baheti, Akanksha Chichra, Mamta Manglani, Ratna Sharma, Rajesh Patil, Ruchira Misra, Ambreen Pandrowala, Pranoti Kini, Purna Kurkure, Girish Chinnaswamy
{"title":"Real-world outcomes of children treated for high-risk neuroblastoma and the challenge in identifying the ultra-high-risk","authors":"Aditi Dwivedi,&nbsp;Venkata Rama Mohan Gollamudi,&nbsp;Sneha Shah,&nbsp;Maya Prasad,&nbsp;Badira Cheriyalinkal Parambil,&nbsp;Sajid Qureshi,&nbsp;Siddhartha Laskar,&nbsp;Nehal Khanna,&nbsp;Vasundara Patel,&nbsp;Akshay Baheti,&nbsp;Akanksha Chichra,&nbsp;Mamta Manglani,&nbsp;Ratna Sharma,&nbsp;Rajesh Patil,&nbsp;Ruchira Misra,&nbsp;Ambreen Pandrowala,&nbsp;Pranoti Kini,&nbsp;Purna Kurkure,&nbsp;Girish Chinnaswamy","doi":"10.1016/j.phoj.2024.11.117","DOIUrl":"10.1016/j.phoj.2024.11.117","url":null,"abstract":"","PeriodicalId":101004,"journal":{"name":"Pediatric Hematology Oncology Journal","volume":"9 4","pages":"Page S4"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142702923","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信